Editing Selective mutism (section)

===Drug treatments===
Some practitioners believe there would be evidence indicating [[anxiolytic]]s to be helpful in treating children and adults with selective mutism,<ref>{{cite web|url=http://www.mentalhelp.net/articles/treatment-of-selective-mutism|title=Treatment Of Selective Mutism|date=21 March 2019 }}{{rs|date=December 2022}}</ref> to decrease anxiety levels and thereby speed the process of therapy. Use of medication may end after nine to twelve months, once the person has learned skills to cope with anxiety and has become more comfortable in social situations.{{fact|date=December 2022}} Medication is more often used for older children, teenagers, and adults whose anxiety has led to depression and other problems.

Medication, when used, should never be considered the entire treatment for a person with selective mutism. However, the reason why medication needs to be considered as a treatment at all is because selective mutism is still prevalent, despite psychosocial efforts. But while on medication, the person should still be in therapy to help them learn how to handle anxiety and prepare them for life without medication, as medication is typically a short-term solution.{{fact|date=December 2022}}

Since selective mutism is categorized as an anxiety disorder, using similar medication to treat either makes sense. Antidepressants have been used in addition to self-modeling and mystery motivation to aid in the learning process.{{explain|date=January 2018}}<ref name="Kehle Madaus Baratta Bray 1998"/><ref name="Shriver Segool Gortmaker 2011"/> Furthermore, [[Selective serotonin reuptake inhibitor|SSRIs]] in particular have been used to treat selective mutism. In a [[systematic review]], ten studies were looked at which involved SSRI medications, and all reported medication was well tolerated.<ref>{{cite journal|last1=Manassis|first1=Katharina|last2=Oerbeck|first2=Beate|last3=Overgaard|first3=Kristen Romvig|title=The use of medication in selective mutism: A systematic review|journal=European Child & Adolescent Psychiatry|date=June 2016|volume=25|issue=6|pages=571–8|pmid=26560144|doi=10.1007/s00787-015-0794-1|s2cid=5859770 }}</ref> In one of them, Black and Uhde (1994) conducted a double-blind, placebo-controlled study investigating the effects of [[fluoxetine]]. By parent report, fluoxetine-treated children showed significantly greater improvement than placebo-treated children. In another, Dummit III et al. (1996) administered fluoxetine to 21 children for nine weeks and found that 76% of the children had reduced or no symptoms by the end of the experiment.<ref>{{cite journal |last1=Dummit |first1=E Steven |last2=Klein |first2=Rachel G. |last3=Asche |first3=Barbara |last4=Martin |first4=Jacqueline |last5=Tancer |first5=Nancy K. |title=Fluoxetine Treatment of Children with Selective Mutism: An Open Trial |journal=Journal of the American Academy of Child & Adolescent Psychiatry |date=May 1996 |volume=35 |issue=5 |pages=615–621 |doi=10.1097/00004583-199605000-00016 |pmid=8935208 |doi-access=free }}</ref> This indicates that fluoxetine is an SSRI that is indeed helpful in treating selective mutism.